Detalhe da pesquisa
1.
Generation of evidence-based carboplatin dosing guidelines for neonates and infants.
Br J Cancer
; 129(11): 1773-1779, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37816842
2.
Loss of ALK hotspot mutations in relapsed neuroblastoma.
Genes Chromosomes Cancer
; 61(12): 747-753, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36029175
3.
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma.
Br J Cancer
; 127(11): 2006-2015, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36175618
4.
Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada.
Environ Health
; 21(1): 30, 2022 03 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35255910
5.
DNA damage checkpoint kinases in cancer.
Expert Rev Mol Med
; 22: e2, 2020 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32508294
6.
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma.
Int J Cancer
; 144(12): 3146-3159, 2019 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30536898
7.
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compression.
Pediatr Blood Cancer
; 66(9): e27825, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31135092
8.
Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.
Br J Cancer
; 115(9): 1048-1057, 2016 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-27701387
9.
Temporal clustering of neuroblastic tumours in children and young adults from Northern England.
Environ Health
; 14: 72, 2015 Sep 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26338008
10.
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38473359
11.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
J Clin Oncol
; 42(10): 1135-1145, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38190578
12.
Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Cancers (Basel)
; 15(21)2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37958407
13.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Clin Cancer Res
; 29(7): 1317-1331, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36602782
14.
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients.
Eur J Cancer
; 164: 127-136, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34657763
15.
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.
Eur J Cancer
; 164: 137-154, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34865945
16.
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Pediatr Hematol Oncol
; 28(2): 106-14, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21214410
17.
Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial.
Cancers (Basel)
; 13(8)2021 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33919763
18.
Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells.
Cancers (Basel)
; 13(24)2021 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34944835
19.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
J Clin Oncol
; 39(30): 3377-3390, 2021 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34115544
20.
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma.
Clin Cancer Res
; 15(4): 1241-9, 2009 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19174487